Skip to content

Scailyte Quarterly Update June 2021

Scailyte’s quarterly update June 2021 on the progress towards its mission to save millions of lives

Scailyte quarterly update

Scailyte quarterly update June, highlighting the discovery of a new biomarker for diagnosing endometriosis. Prof Michael Brenner (Harvard Medical School) joined as a scientific advisor to support the Board and management in defining our clinical and R&D strategy. Here is his statement about our company – “With their approach to leverage single-cell data and artificial intelligence for biomarker discovery, Scailyte is spot on, doing something that has huge potential and at the right time.” Read more below:

Read our previous quarterly update here.

About Scailyte

Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets. 

Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.

For more information, visit www.scailyte.com and connect on social media @LinkedIn and @Twitter.

ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.

Recent News

PAPER: Mapping single-cell data - Nature Biotech

Large single-cell atlases are now routinely generated to serve as references for the analysis of sma

Read more

Recent News

Scailyte Closes Financing Round and Onboards Top Biotech Leaders

Scailyte has successfully finished the first closing of their series A. Two new investors joined the

Read more

Recent News

Scailyte Quarterly Update December 2021

December 2021 Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Recent News

VACANCY: Regulatory Affairs / Quality Management Specialist

We are currently developing a first-in-class in vitro diagnostic tool for Endometriosis aiming at cu

Read more

Recent News

Why single-cell technologies are vital for Endometriosis research webinar

Prof. Dr Michael D. Mueller is an expert in endometriosis and women’s health. The complexity of th

Read more

Recent News

Single-Cell Discovery Grant in Oncology and Immunology

Open grant call of up to 100K Euro aimed at addressing unmet clinical needs in Oncology and Immunolo

Read more

Recent News

Scailyte and Lexogen create a joint biomarker discovery workflow

Scailyte, a single-cell biomarker discovery company and Lexogen, a leader in RNA sequencing solution

Read more

Recent News

Scailyte Quarterly Update June 2021

June 2021 Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Recent News

01 /04

PAPER: Mapping single-cell data - Nature Biotech

Large single-cell atlases are now routinely generated to serve as references for the analysis of sma

Read more

Scailyte Closes Financing Round and Onboards Top Biotech Leaders

Scailyte has successfully finished the first closing of their series A. Two new investors joined the

Read more

Recent News

02 /04

Scailyte Quarterly Update December 2021

December 2021 Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

VACANCY: Regulatory Affairs / Quality Management Specialist

We are currently developing a first-in-class in vitro diagnostic tool for Endometriosis aiming at cu

Read more

Recent News

03 /04

Why single-cell technologies are vital for Endometriosis research webinar

Prof. Dr Michael D. Mueller is an expert in endometriosis and women’s health. The complexity of th

Read more

Single-Cell Discovery Grant in Oncology and Immunology

Open grant call of up to 100K Euro aimed at addressing unmet clinical needs in Oncology and Immunolo

Read more

Recent News

04 /04

Scailyte and Lexogen create a joint biomarker discovery workflow

Scailyte, a single-cell biomarker discovery company and Lexogen, a leader in RNA sequencing solution

Read more

Scailyte Quarterly Update June 2021

June 2021 Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Recent News